-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
About 250 million people worldwide are infected with hepatitis B virus (HBV) and are in various stages of liver degeneration, such as hepatic steatosis, cirrhosis, end-stage liver failure or hepatocellular carcinoma
+ + + + + + +
The results of this study provide new insights into how the CCL19/CCR7 axis regulates the host immune system.
The results of this study provide new insights into how the CCL19/CCR7 axis regulates the host immune system.
Original source:
Yan Yan.
CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance.
Leave a message here